NEW YORK – CVS Health (NYSE: CVS) is exploring options that could include a break-up of the company to separate
1 year ago
Pfizer (NYSE: PFE) sold a stake in British consumer healthcare group Haleon (NYSE: HLN) worth about $3.26 billion on Monday,
On Monday, Bristol Myers Squibb (NYSE: BMY) won the dismissal of a $6.4 billion lawsuit claiming it cheated former Celgene
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott (NYSE: ABT), Reckitt’s Mead
LONDON – Brookfield (NYSE: BN), a Canadian fund, reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols (NASDAQ:
Grifols (NASDAQ: GRFS), the Spanish drugmaker, plans to invest 360 million euros ($401.98 million) to build a new industrial plant
Investing in the healthcare sector can be lucrative and complex, particularly in biotechnology (biotech) and pharmaceuticals (pharma). Both sectors offer
The U.S. Food and Drug Administration approved GE HealthCare’s (NASDAQ: GEHC) diagnostic drug for use in the detection of coronary
Haleon (NYSE: HLN) plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer
On Thursday, the European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer’s (NYSE: PFE) sickle cell disease drug
Pfizer’s (NYSE: PFE) decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death
Evotec (NASDAQ: EVO), the German drug and development company, has entered into a technology development partnership with Novo Nordisk (NYSE:
